REGN - Intellia sued for patent infringement by gene editing company BlueAllele
2024-07-08 18:11:27 ET
More on Intellia Therapeutics
- Intellia Therapeutics Presents Promising In Vivo CRISPR Results
- Intellia Therapeutics: 3 Near-Term Pivotal In Vivo Gene Therapies
- Intellia Therapeutics, Inc. (NTLA) Q1 2024 Earnings Call Transcript
- Intellia rallies on Phase 1 data for CRISPR-based HAE therapy
- Intellia Therapeutics Q1 2024 Earnings Preview